Oklo Aims to Reach Criticality at Groves Isotopes Test Reactor by July
Oklo (OKLO) has seen its stock decline significantly in early 2026 due to a lack of major project updates. However, the company is on track for an important milestone with its Groves Isotopes Test Reactor reaching criticality by July 4 after receiving regulatory approvals. This development could provide much-needed momentum and investor confidence.
Topics: nuclear energy regulatory progress small modular reactors (SMR)